�BILL ANALYSIS

Senate Research Center	S.B. 1986
89R12070 CJD-D	By: Hall
	Health & Human Services
	4/25/2025
	As Filed

AUTHOR'S / SPONSOR'S STATEMENT OF INTENT

Pharmacists, unfortunately, often find themselves in the difficult position of needing to dispense or deliver opioids to patients who require them for pain management or other medical purposes. While the use of opioids is not something that should be eliminated entirely�since they remain an essential tool in treating certain conditions�there is an overwhelming need for caution and vigilance when prescribing or dispensing these powerful substances. It is crucial that healthcare providers, including pharmacists, ensure that patients are fully informed about the potential risks associated with opioid use. This means not only explaining the possible side effects in clear and accessible terms, but also taking the necessary steps to make sure patients understand the gravity of these risks. Opioids inherently carry a high potential for addiction, and their misuse can quickly escalate into severe health complications, including physical dependence, debilitating illness, and, tragically, overdose. Given the current opioid crisis, it is more important than ever for healthcare professionals to prioritize education and prevention. Alongside their duty to provide pain relief, pharmacists must also emphasize safe usage, monitor for signs of misuse, and explore alternative treatment options when appropriate. Ultimately, ensuring patients have a full understanding of the potential consequences�and are supported in making informed decisions�should be a fundamental part of the opioid dispensing process.

As proposed, S.B. 1986 amends current law relating to warning labels for opioid prescription drugs.

RULEMAKING AUTHORITY

Rulemaking authority is expressly granted to the Texas State Board of Pharmacy in SECTION 2 (Section 481.0761, Health and Safety Code) of this bill.

SECTION BY SECTION ANALYSIS

SECTION 1. Amends Section 481.074(a), Health and Safety Code, as follows:

(a) Prohibits a pharmacist from dispensing an opioid unless the bottle or container in which the opioid is dispensed is affixed with a label warning of the addictive nature of opioids and the risks of respiratory depression and overdose as required by Texas State Board of Pharmacy (TSBP) rule under Section 481.0761(l). Makes nonsubstantive changes.

SECTION 2. Amends Section 481.0761, Health and Safety Code, by adding Subsection (l), as follows:

(l) Requires TSBP to adopt rules requiring that an opioid be dispensed in a bottle or container affixed with a label warning users of the addictive nature of opioids and the risks of respiratory depression and overdose. Requires that the label include language substantially similar to "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose.".

SECTION 3. Requires TSBP to adopt the rules required under Section 481.0761(l), Health and Safety Code, as added by this Act, not later than January 1, 2026.

SECTION 4. Makes application of this Act prospective to March 1, 2026.

SECTION 5. Effective date: upon passage or September 1, 2025.